
David Healy, Professor of Psychiatry at the Hergest psychiatric unit in North Wales claimed that depression is not due to the low levels of serotonin in the brain.
David pointed to a misconception that lowered serotonin levels in depression are an established fact and that effective treatments raise these levels, which he described as "the marketing of a myth."
Advertisement
Healy suggested that the myth "co-opted" many, including the complementary health market, psychologists, and journals. But above all the myth co-opted doctors and patients, he said; for doctors it provided an easy short hand for communication with patients.
For patients, the idea of correcting an abnormality has a moral force that can be expected to overcome the scruples some might have had about taking a tranquilizer, especially when packaged in the appealing form that distress was not a weakness, he further added.
Source: ANI
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News

Injury to the white matter explains why football players are at an increased risk for cognitive and behavioral problems later in life.

Located at the South Col, the rocky area between Mount Everest and Lhotse serves as the final campsite for climbers as well as a frozen legacy of hardy microbes.

The new finding is found to be valuable for screening specific medications and treatment against Giardia and other protozoan parasites.

New CRISPR genome-editing strategy was found to have a positive impact in the treatment of inherited retinal diseases such as retinitis pigmentosa.

H3N2 Influenza: The newly developed RT-qPCR Kit to identify influenza, COVID-19 and respiratory virus has got approval from ICMR.